Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects

Richard F. Brubaker, Cory Ingram, Erik O. Schoff, Cherie B. Nau

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: To compare the efficacy of combinations of betaxolol- brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow and ocular hypotensive agents. Design: Placebo-controlled, masked comparison of the two drug combinations. Participants: Twenty-five normal human volunteers with the fellow eye serving as control. Methods or Testing: Fluorophotometric measurement of aqueous humor flow and pneumatonometric measurement of intraocular pressure. Main Outcome Measures: Aqueous humor flow and intraocular pressure. Results: The betaxolol-brinzolamide combination lowered aqueous flow 39% to 44%, and the timolol-dorzolamide combination lowered aqueous flow 51%. The betaxolol-brinzolamide combination lowered intraocular pressure 14% to 19%, and the timolol-dorzolamide combination lowered it 18% to 24%. Conclusions: Both drug combinations were effective; the timolol- dorzolamide combination appeared to be the more effective of the two after short-term exposure (24 hours). (C) 2000 by the Mayo Foundation.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalOphthalmology
Volume107
Issue number2
DOIs
StatePublished - Feb 1 2000

Fingerprint

dorzolamide
Betaxolol
Timolol
Aqueous Humor
Intraocular Pressure
Drug Combinations
Healthy Volunteers
Placebos
Outcome Assessment (Health Care)
dorzolamide-timolol combination
brinzolamide

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects. / Brubaker, Richard F.; Ingram, Cory; Schoff, Erik O.; Nau, Cherie B.

In: Ophthalmology, Vol. 107, No. 2, 01.02.2000, p. 283-287.

Research output: Contribution to journalArticle

@article{51d3487f0c734bdb820eb6208e4f2733,
title = "Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects",
abstract = "Objective: To compare the efficacy of combinations of betaxolol- brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow and ocular hypotensive agents. Design: Placebo-controlled, masked comparison of the two drug combinations. Participants: Twenty-five normal human volunteers with the fellow eye serving as control. Methods or Testing: Fluorophotometric measurement of aqueous humor flow and pneumatonometric measurement of intraocular pressure. Main Outcome Measures: Aqueous humor flow and intraocular pressure. Results: The betaxolol-brinzolamide combination lowered aqueous flow 39{\%} to 44{\%}, and the timolol-dorzolamide combination lowered aqueous flow 51{\%}. The betaxolol-brinzolamide combination lowered intraocular pressure 14{\%} to 19{\%}, and the timolol-dorzolamide combination lowered it 18{\%} to 24{\%}. Conclusions: Both drug combinations were effective; the timolol- dorzolamide combination appeared to be the more effective of the two after short-term exposure (24 hours). (C) 2000 by the Mayo Foundation.",
author = "Brubaker, {Richard F.} and Cory Ingram and Schoff, {Erik O.} and Nau, {Cherie B.}",
year = "2000",
month = "2",
day = "1",
doi = "10.1016/S0161-6420(99)00044-5",
language = "English (US)",
volume = "107",
pages = "283--287",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects

AU - Brubaker, Richard F.

AU - Ingram, Cory

AU - Schoff, Erik O.

AU - Nau, Cherie B.

PY - 2000/2/1

Y1 - 2000/2/1

N2 - Objective: To compare the efficacy of combinations of betaxolol- brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow and ocular hypotensive agents. Design: Placebo-controlled, masked comparison of the two drug combinations. Participants: Twenty-five normal human volunteers with the fellow eye serving as control. Methods or Testing: Fluorophotometric measurement of aqueous humor flow and pneumatonometric measurement of intraocular pressure. Main Outcome Measures: Aqueous humor flow and intraocular pressure. Results: The betaxolol-brinzolamide combination lowered aqueous flow 39% to 44%, and the timolol-dorzolamide combination lowered aqueous flow 51%. The betaxolol-brinzolamide combination lowered intraocular pressure 14% to 19%, and the timolol-dorzolamide combination lowered it 18% to 24%. Conclusions: Both drug combinations were effective; the timolol- dorzolamide combination appeared to be the more effective of the two after short-term exposure (24 hours). (C) 2000 by the Mayo Foundation.

AB - Objective: To compare the efficacy of combinations of betaxolol- brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow and ocular hypotensive agents. Design: Placebo-controlled, masked comparison of the two drug combinations. Participants: Twenty-five normal human volunteers with the fellow eye serving as control. Methods or Testing: Fluorophotometric measurement of aqueous humor flow and pneumatonometric measurement of intraocular pressure. Main Outcome Measures: Aqueous humor flow and intraocular pressure. Results: The betaxolol-brinzolamide combination lowered aqueous flow 39% to 44%, and the timolol-dorzolamide combination lowered aqueous flow 51%. The betaxolol-brinzolamide combination lowered intraocular pressure 14% to 19%, and the timolol-dorzolamide combination lowered it 18% to 24%. Conclusions: Both drug combinations were effective; the timolol- dorzolamide combination appeared to be the more effective of the two after short-term exposure (24 hours). (C) 2000 by the Mayo Foundation.

UR - http://www.scopus.com/inward/record.url?scp=0034029713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034029713&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(99)00044-5

DO - 10.1016/S0161-6420(99)00044-5

M3 - Article

C2 - 10690826

AN - SCOPUS:0034029713

VL - 107

SP - 283

EP - 287

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 2

ER -